ClinicalTrials.Veeva

Menu

The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man

U

University of Edinburgh

Status

Completed

Conditions

Ischaemic Heart Diseases

Treatments

Procedure: Forearm vascular study

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Heart attacks are usually caused by a blood clot blocking an artery supplying blood to the heart. Current treatments are designed at relieving this blockage as quickly as possible to minimise damage to the heart muscle. However in restoring the supply of blood local damage known as "ischaemia-reperfusion injury" may occur. The aim of this study is to assess how clot forming and clot dissolving pathways are affected during this process, and examine the role of a natural inflammatory hormone, bradykinin. This will help us to understand the mechanism by which ischaemia-reperfusion injury may occur and to devise new treatments for heart attacks.

Enrollment

12 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy males between 18-65 years of ages, non-smokers.

Exclusion criteria

  • Any concurrent illness or chronic medical condition. Concurrent use of vasoactive medication. Smoking history.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

12 participants in 2 patient groups

1
Sham Comparator group
Description:
no ischaemia - only sham. Blood pressure cuff inflation up till 10 mmHg on the upper arm for 20 mins.
Treatment:
Procedure: Forearm vascular study
2
Active Comparator group
Description:
Ischaemia 20 minutes. Blood pressure cuff will be inflated around the upper arm for 20 minutes to induce ischaemia.
Treatment:
Procedure: Forearm vascular study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems